U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty
Affiliations
- PMID: 17915393
Item in Clipboard
U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty
Food Drug Law J.
2007.
No abstract available
Similar articles
-
Compliance in European pharmacovigilance: a regulatory view.Pharmacoepidemiol Drug Saf. 2001 Jun-Jul;10(4):301-2. doi: 10.1002/pds.620. Pharmacoepidemiol Drug Saf. 2001. PMID: 11760490 No abstract available.
-
The unfinished business of U.S. drug safety regulation.Food Drug Law J. 2006;61(1):45-63. Food Drug Law J. 2006. PMID: 16838457 No abstract available.
-
The role of databases in drug postmarketing surveillance.Pharmacoepidemiol Drug Saf. 2001 Aug-Sep;10(5):407-10. doi: 10.1002/pds.615. Pharmacoepidemiol Drug Saf. 2001. PMID: 11802586
-
Post-marketing surveillance and adverse drug reactions.Isr Med Assoc J. 1999 Oct;1(2):117-9. Isr Med Assoc J. 1999. PMID: 10731310 Review. No abstract available.
-
Postmarketing surveillance and other epidemiologic uses of drug prescription data in the United States.Ann Ist Super Sanita. 1991;27(2):235-7. Ann Ist Super Sanita. 1991. PMID: 1755576 Review.